Effect of antisecretory factor, given as a food supplement to adult patients with severe traumatic brain injury (SASAT): protocol for an exploratory randomized double blind placebo-controlled trial

BACKGROUND: Traumatic brain injury (TBI) constitutes a global epidemic. Overall outcome is poor, with mortality ranging from 10 to 70% and significant long-term morbidity. Several experimental reports have claimed effect on traumatic edema, but no clinical trials have shown effect on edema or outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cederberg, David, Harrington, Bradley M., Vlok, Adriaan Johannes, Siesjö, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034076/
https://www.ncbi.nlm.nih.gov/pubmed/35461285
http://dx.doi.org/10.1186/s13063-022-06275-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034076/
https://www.ncbi.nlm.nih.gov/pubmed/35461285
http://dx.doi.org/10.1186/s13063-022-06275-z

Ejemplares similares